We have data on 146 companies that use MedeAnalytics. The companies using MedeAnalytics are most often found in United States and in the Hospital & Health Care industry. MedeAnalytics is most often used by companies with >10000 employees and >1000M dollars in revenue. Our data for MedeAnalytics usage goes back as far as 6 years and 5 months.
|Company||Blue Cross Blue Shield Association|
|Company||EPAM Systems Inc|
|Company||University of Maryland|
|Company||Capital One Financial Corporation|
|Company||University of Washington|
|Blue Cross Blue Shield Association||bcbs.com||United States||>1000M||1000-5000|
|EPAM Systems Inc||epam.com||United States||>1000M||>10000|
|University of Maryland||umd.edu||United States||>1000M||>10000|
|Capital One Financial Corporation||capitalone.com||United States||>1000M||>10000|
|University of Washington||washington.edu||United States||>1000M||>10000|
We use the best indexing techniques combined with advanced data science to monitor the market share of over 15,000 technology products, including Healthcare. By scanning billions of public documents, we are able to collect deep insights on every company, with over 100 data fields per company at an average. In the Healthcare category, MedeAnalytics has a market share of about 0.1%. Other major and competing products in this category include:
MedeAnalytics provides evidence-based insights to solve a real problem that plagues healthcare - how to use the immense amount of patient data collected across health and care settings to deliver cost-effective care and improve patient outcomes in an integrated way.
Looking at MedeAnalytics customers by industry, we find that Hospital & Health Care (42%), Information Technology and Services (11%), Insurance (8%) and Computer Software (6%) are the largest segments.
88% of MedeAnalytics customers are in United States.
Of all the customers that are using MedeAnalytics, a majority (54%) are large (>1000 employees), 24% are small (<50 employees) and 16% are medium-sized.
Of all the customers that are using MedeAnalytics, a majority (55%) are large (>$1000M), 29% are small (<$50M) and 7% are medium-sized.